At the Mount Sinai School of Medicine in New York, researchers followed serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), and @entity1420 in 5 @entity1 treated with @entity1 menopausal gonadotropin (HMG) and @entity1 chorionic gonadotropin (HCG) for induction of ovulation. A total of 7 treatment cycles were followed. In 5 of the cycles conception occurred. Values in the 5 cycles in which conception occurred were dissimilar to values in normal menstrual cycles. Thus, efforts to mimic normal gonadotropin elaboration are probably unnecessary in the treatment of anovulatory @entity1 . Significant variation in values occurred among the @entity1 . A midcycle FSH peak concomitant with the LH surge was clearly seen to be unnecessary for ovulation induction. Following ovulation a general decline in FSH occurred. FSH apparently was suppressed during the gestational period. In @entity1 who had elevated pretreatment serum LH levels, LH apparently was suppressed during the first 1/2 of the HMG therapy; however, during the latter 1/2 of the HMG therapy, LH rose in these @entity1 . Therapy-induced multiple ovulation with resultant multiple corpora lutea caused serum @entity1420 levels to rise to 2-3 times those of normal singleton gestations. Implantation appeared to have occurred 8-9 days after ovulation induction. The 5 pregnancies resulted in 3 term deliveries, 1 first-trimester spontaneous abortion, and a quadruplet premature delivery.

Serum follicle-stimulating and luteinizing hormone and XXXX in single and multiple gestations following induction of ovulation.

@entity1 :: ('9606', 'Species') :: ['human', 'patients', 'women'] @entity1420 :: ('MESH:D011374', 'Chemical') :: ['progesterone']
@entity1420 :: (MESH:D011374,Chemical) :: ['progesterone']
